Miguel Arcinas is an accomplished executive with a remarkable background in the biotech and pharmaceutical industries. He pursued his undergraduate studies at the University of California, Los Angeles, earning a degree in Microbiology, Immunology, and Molecular Genetics. Later, he obtained a Master of Business Administration with a specialization in Finance and Entrepreneurship from The University of Chicago Booth School of Business.

Arcinas has served in numerous leadership positions, most recently as Vice President of Corporate Development and Investor Relations at Silverback Therapeutics. Before that, he led corporate development and investor relations as Executive Director and Senior Director also at Silverback Therapeutics, Associate Director at Synthorx Inc, Senior Manager at ACADIA Pharmaceuticals Inc., and Clinical Trial Manager in Oncology at AbbVie.

With his strong financial acumen and an extensive track record in corporate development and investor relations, Arcinas places a high priority on driving operational excellence and effective collaboration to achieve exceptional results for his organization.